Diet pills and apps: trends 2026

The market for weight loss drugs is evolving thanks to GLP-1 tablets from Novo Nordisk and Eli Lilly. Experts predict growth to $150 billion, with an emphasis on telemedicine, apps and direct sales.

Weight loss drugs based on GLP-1 radically change the approach to the fight against obesity, turning treatment into a convenient consumer product, writes xrust. Pharma executives see the future in monthly subscriptions, mobile apps for dosage monitoring and easy access through online platforms, similar to online shopping. This will allow us to reach millions of people who want to lose weight without complex procedures.

Weight loss drugs: from injections to tablets

The move to oral forms of drugs such as Novo Nordisk's Wegovy and Eli Lilly's orforglipron opens up new opportunities. Taken daily, these tablets are ideal for those who avoid injections. Analysts note the following advantages:

• Flexibility in dosage: possibility of microdoses for gradual weight loss.
• Seasonal programs: use during the holidays or “swimsuit season” to maintain shape.
• Post-weight loss support: switch to low doses to maintain results without the risk of weight gain.

According to experts, such forms will make treatment more affordable, especially through cash payments, bypassing insurance restrictions. Prices start at $149 per month for initial doses and go up to $399 for ongoing doses, which is less than the cost of injections.

The role of telemedicine and apps in the market

Companies like Noom, Ro, and WeightWatchers are integrating GLP-1 medications with virtual consultations and monitoring apps. Patients receive appointment reminders, nutrition tips, and progress tracking right on their smartphone. As Welldoc's Katherine Brown noted: «GLP-1 applications will become everyday applications, like banking or weather services.»

Exclusive expert commentary: According to PwC analysts, GLP-1 drugs are causing a shift in consumer behavior comparable to the influence of the Internet on shopping, stimulating demand for a healthy lifestyle and reducing food costs. This adds a unique aspect: patients not only lose weight, but also change habits, which enhances the long-term effect.

Marketing through TikTok and Reddit uses memes and testimonials from celebrities such as Oprah Winfrey or Elon Musk to raise awareness. Advantages of online platforms:

• Quick access to prescriptions without waiting for a doctor.
• Anonymity for discussing weight problems.
• Integration with services to improve energy, skin and intimate life.

However, experts warn of the risks: side effects include stomach problems, depression and rare complications. Dr. Robert Kushner emphasizes the need for medical oversight for safe use.

Financial and social implications

Eli Lilly's market capitalization exceeded a trillion dollars thanks to GLP-1, and Novo Nordisk became a leader in Europe. Manufacturers are partnering with Amazon and telemedicine to hire consumer marketers. Lilly CEO Dave Ricks said: “People are aware of their weight; the health care system is not always needed.”

Background

Obesity affects three-quarters of American adults, but only 12% use GLP-1 drugs. Tablets can increase this share by creating a consumer channel without intermediaries. The market will grow to $150 billion by 2030, with a focus on prevention and weight maintenance. Historically, GLP-1 has changed diabetes and heart treatment, but now focuses on lifestyle.

Xrust Diet Pills and Apps: Trends 2026